Dexanabinol
Title: Dexanabinol
CAS Registry Number: 112924-45-5
CAS Name: (6aS,10aS)-3-(1,1-Dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol
Additional Names: (+)-(3S,4S)-7-hydroxy-D6-tetrahydrocannabinol-1,1-dimethylheptyl; (+)-11-OH-D8-THC-DMH
Manufacturers' Codes: HU-211
Molecular Formula: C25H38O3
Molecular Weight: 386.57
Percent Composition: C 77.67%, H 9.91%, O 12.42%
Literature References: NMDA antagonist. Nonpsychotropic derivative of tetrahydrocannabinol, q.v. Prepn: R. Mechoulam et al., DE 3735990; eidem, US 4876276 (1988, 1989 both to Yissum Res. Dev. Co.); R. Mechoulam et al., Tetrahedron: Asymmetry 1, 315 (1990). Cannabinoid receptor binding study: A. C. Howlett et al., Neuropharmacology 29, 161 (1990). Inhibition of nuclear factor-kB (NF-kB): E. Jüttler et al., Neuropharmacology 47, 580 (2004). Pharmacology: N. Eshhar et al., Eur. J. Pharmacol. 283, 19 (1995). Clinical pharmacokinetics: M. E. Brewster et al., Int. J. Clin. Pharmacol. Ther. 35, 361 (1995). Clinical evaluation in severe head injury: N. Knoller et al., Crit. Care Med. 30, 548 (2002).
Properties: Crystals from pentane, mp 141-142°. [a]D +227° (CHCl3).
Melting point: mp 141-142°
Optical Rotation: [a]D +227° (CHCl3)
Therap-Cat: Neuroprotective.
Keywords: Neuroprotective; NMDA Receptor Antagonist.

Others monographs:
HeliosupinePidotimodMuira PuamaMelphalan
Tantalum PentafluorideMenthyl SalicylateErtapenemDiacetylmorphine
Dehydroacetic Acid2-Ethyl-1-hexanolIndolebutyric Acidn-Butyl Propionate
NeriifolinMCPABendiocarbCamostat
©2016 DrugLead US FDA&EMEA